986 related articles for article (PubMed ID: 17958624)
1. Correlation of mucocutaneous manifestations of HIV/AIDS infection with CD4 counts and disease progression.
Nnoruka EN; Chukwuka JC; Anisuiba B
Int J Dermatol; 2007 Oct; 46 Suppl 2():14-8. PubMed ID: 17958624
[TBL] [Abstract][Full Text] [Related]
2. Patterns of skin manifestations and their relationships with CD4 counts among HIV/AIDS patients in Cameroon.
Josephine M; Issac E; George A; Ngole M; Albert SE
Int J Dermatol; 2006 Mar; 45(3):280-4. PubMed ID: 16533229
[TBL] [Abstract][Full Text] [Related]
3. Skin disease: clinical indicator of immune status in human immunodeficiency virus (HIV) infection.
Raju PV; Rao GR; Ramani TV; Vandana S
Int J Dermatol; 2005 Aug; 44(8):646-9. PubMed ID: 16101864
[TBL] [Abstract][Full Text] [Related]
4. Spectrum of skin disorders in human immunodeficiency virus-infected patients in Singapore and the relationship to CD4 lymphocyte counts.
Goh BK; Chan RK; Sen P; Theng CT; Tan HH; Wu YJ; Paton NI
Int J Dermatol; 2007 Jul; 46(7):695-9. PubMed ID: 17614796
[TBL] [Abstract][Full Text] [Related]
5. Oro-facial lesions and CD4 counts associated with HIV/AIDS in an adult population in Oyo State, Nigeria.
Adurogbangba MI; Aderinokun GA; Odaibo GN; Olaleye OD; Lawoyin TO
Oral Dis; 2004 Nov; 10(6):319-26. PubMed ID: 15533205
[TBL] [Abstract][Full Text] [Related]
6. CD4+ T-lymphocytes cell counts in adults with human immunodeficiency virus infection at the medical department of a tertiary health institution in Nigeria.
Ajayi AO; Ajayi EA; Fasakin KA
Ann Afr Med; 2009; 8(4):257-60. PubMed ID: 20139549
[TBL] [Abstract][Full Text] [Related]
7. Mantoux reaction in patients with HIV-related pulmonary tuberculosis in Maiduguri, Nigeria.
Yusuph H; Garbati MA; Gashau W
Afr J Med Med Sci; 2005 Jun; 34(2):125-8. PubMed ID: 16749335
[TBL] [Abstract][Full Text] [Related]
8. Relationship between clinical conditions and CD4 counts in HIV-infected persons in Pune, Maharashtra, India.
Ghate MV; Mehendale SM; Mahajan BA; Yadav R; Brahme RG; Divekar AD; Paranjape RS
Natl Med J India; 2000; 13(4):183-7. PubMed ID: 11002684
[TBL] [Abstract][Full Text] [Related]
9. Neurological complications in patients with HIV/AIDS.
Bolokadze N; Gabunia P; Ezugbaia M; Gatserelia L; Khechiashvili G
Georgian Med News; 2008 Dec; (165):34-8. PubMed ID: 19124914
[TBL] [Abstract][Full Text] [Related]
10. Correlation of mucocutaneous manifestations of HIV-infected patients in an ART center with CD4 counts.
Lahoti S; Rao K; Umadevi HS; Mishra L
Indian J Dent Res; 2017; 28(5):549-554. PubMed ID: 29072219
[TBL] [Abstract][Full Text] [Related]
11. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].
Panel de expertos de Gesida y Plan Nacional sobre el Sida
Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):222-35. PubMed ID: 19246124
[TBL] [Abstract][Full Text] [Related]
12. CD4 cell count and HIV DNA level are independent predictors of disease progression after primary HIV type 1 infection in untreated patients.
Goujard C; Bonarek M; Meyer L; Bonnet F; Chaix ML; Deveau C; Sinet M; Galimand J; Delfraissy JF; Venet A; Rouzioux C; Morlat P;
Clin Infect Dis; 2006 Mar; 42(5):709-15. PubMed ID: 16447119
[TBL] [Abstract][Full Text] [Related]
13. Susceptibility to opportunistic infections in HIV-infected patients with increased CD4 T-cell counts on antiretroviral therapy may be predicted by markers of dysfunctional effector memory CD4 T cells and B cells.
French M; Keane N; McKinnon E; Phung S; Price P
HIV Med; 2007 Apr; 8(3):148-55. PubMed ID: 17461858
[TBL] [Abstract][Full Text] [Related]
14. Anticardiolipin antibodies in HIV infection are independently associated with antibodies to the membrane proximal external region of gp41 and with cell-associated HIV DNA and immune activation.
Martinez V; Diemert MC; Braibant M; Potard V; Charuel JL; Barin F; Costagliola D; Caumes E; Clauvel JP; Autran B; Musset L;
Clin Infect Dis; 2009 Jan; 48(1):123-32. PubMed ID: 19035778
[TBL] [Abstract][Full Text] [Related]
15. Monitoring antiretroviral therapy in HIV/AIDS patients in resource-limited settings: CD4 counts or total lymphocyte counts?
Mbanya D; Assah F; Ndembi N; Kaptue L
Int J Infect Dis; 2007 Mar; 11(2):157-60. PubMed ID: 16762583
[TBL] [Abstract][Full Text] [Related]
16. Circulating memory B-cell subpopulations are affected differently by HIV infection and antiretroviral therapy.
D'Orsogna LJ; Krueger RG; McKinnon EJ; French MA
AIDS; 2007 Aug; 21(13):1747-52. PubMed ID: 17690573
[TBL] [Abstract][Full Text] [Related]
17. Use of total lymphocyte count for monitoring response to antiretroviral therapy.
Schreibman T; Friedland G
Clin Infect Dis; 2004 Jan; 38(2):257-62. PubMed ID: 14699459
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of dermatological disorders in Thai HIV-infected patients correlated with different CD4 lymphocyte count statuses: a note on 120 cases.
Wiwanitkit V
Int J Dermatol; 2004 Apr; 43(4):265-8. PubMed ID: 15090008
[TBL] [Abstract][Full Text] [Related]
19. Lower Helicobacter pylori infection and peptic ulcer disease prevalence in patients with AIDS and suppressed CD4 counts.
Cacciarelli AG; Marano BJ; Gualtieri NM; Zuretti AR; Torres RA; Starpoli AA; Robilotti JG
Am J Gastroenterol; 1996 Sep; 91(9):1783-4. PubMed ID: 8792698
[TBL] [Abstract][Full Text] [Related]
20. Profile of central nervous system disease in HIV/AIDS patients with special reference to cryptococcal infections.
Wadhwa A; Kaur R; Bhalla P
Neurologist; 2008 Jul; 14(4):247-51. PubMed ID: 18617851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
